Litigation Details for Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)
✉ Email this page to a colleague
Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-08-06 |
| Court | District Court, W.D. Texas | Date Terminated | 2019-08-13 |
| Cause | 35:271 Patent Infringement | Assigned To | Earl Leroy Yeakel III |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 7,828,787; 8,118,802; 8,162,915 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Fresenius Kabi USA, LLC v. Custopharm, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-04-17 | 37 | Amended Complaint | States Patent Nos. 8,118,802 (“the ‘802 patent”), 8,162,915 (“the ‘915 patent”), and 7,828,787 (“the … COUNT III FOR INFRINGEMENT OF U.S. PATENT NO. 7,828,787 66. The allegations of paragraphs… ‘787 patent”) (collectively, “the Patents-in-Suit”). This action arises out of Defendant’s filing of… BACKGROUND The Patents-in-Suit 24. The ‘802 patent, entitled “Connector for packaging…inventors assigned the ‘802 patent to Fresenius Kabi Deutschland GmbH. The ‘802 patent is listed in the Orange | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
